{"id":3844,"date":"2017-01-25T12:07:37","date_gmt":"2017-01-25T11:07:37","guid":{"rendered":"https:\/\/staging.blogs.yokogawa.de\/chemical-pharma\/unkategorisiert\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/"},"modified":"2022-07-04T06:53:48","modified_gmt":"2022-07-04T04:53:48","slug":"offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit","status":"publish","type":"post","link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/","title":{"rendered":"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit"},"content":{"rendered":"<blockquote><p><strong><em>Sich Neuen Technologien \u00f6ffnen, aber bei der Sicherheit keine Kompromisse machen.<\/em><\/strong><\/p><\/blockquote>\n<p><strong>Dr. Krauss, BASF<\/strong>, sagt noch viel mehr in seinem <a href=\"https:\/\/www.youtube.com\/watch?v=mgMVIPvEe3Q\">Interview<\/a> \u00fcber NAMUR Open Architecture auf der <a href=\"http:\/\/www.namur.net\/de\/publikationen\/news-archiv\/detail\/article\/namur-hauptsitzung-2016loesungen-zur-optimierung-in-der-globalen-prozessindustrie.html\">NAMUR-Hauptsitzung 2016<\/a>. Trotzdem bringt die Aussage es auf den Punkt. Mit der NAMUR Open Architecture (NOA) werden hier zurzeit neue Anforderungen \u00a0an die Architektur von Automatisierungssystemen diskutiert.<\/p>\n<h3>Ganzes Statement von Dr. Krauss ansehen!<\/h3>\n<h3>Yokogawas Version einer offenen Architektur<\/h3>\n<p>Dr. Helget, MD Deutschland, hat in der Keynote \u201eL\u00f6sungen zur Optimierung in der globalen Prozessindustrie\u201c Yokogawas Vision einer offenen Architektur bereits vorgestellt.<\/p>\n<p><span style=\"color: #ff0000\"><span style=\"color: #000000\">[ot-caption title=&#8220;Keynote-Slide: Offene Architektur \u2013 flexibel und zukunftssicher&#8220; url=&#8220;https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/app\/uploads\/2017\/01\/OpAr_Keynote_slide.png&#8220;]<\/span><br \/>\n<\/span><\/p>\n<h3>Keynote-Ausschnitt ansehen!<\/h3>\n<h3>Der Anfang ist gemacht<\/h3>\n<p>Den ersten Schritt hin zu einer offenen Architektur ist Yokogawa bereits gegangen. Mit der im September 2016 vorgestellten Version 2 der Unified Gateway Station (UGS2) kommt diese ohne die bisher ben\u00f6tigte systemeigene <a href=\"http:\/\/www.yokogawa.com\/de\/dcs\/offene_systemarchi\/de-vnet_ip.htm?nid=left\"> VNet\/IP Schnittstellenkarte<\/a> aus und nutzt stattdessen Standard Ethernet Technologien.<\/p>\n<p>[ot-caption title=&#8220;Unified Gateway Station 2: Fremdsysteme lassen sich \u00fcber eine Vielzahl von Schnittstellenprotokollen nahtlos in das Prozessleitsystem\u00a0 integrieren.&#8220; url=&#8220;https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/app\/uploads\/2017\/01\/openAr_UGS_DCS_Bild.png&#8220;]<\/p>\n<h3>Sicherheit geht vor<\/h3>\n<p>Bei der Sicherheit werden durch den Einsatz der\u00a0<a href=\"http:\/\/www.yokogawa.com\/de\/dcs\/offene_systemarchi\/de-vnet_ip.htm?nid=left\">VNet\/IP-Technologie<\/a> nach IEC 62405 keine Kompromisse gemacht. Neben der Vielzahl der unterst\u00fctzten Kommunikationsprotokolle (OPC, Modbus, Ethernet\/IP und andere) sind vor allem die Leistungsparameter beachtlich:<\/p>\n<ul>\n<li>Redundanz*<\/li>\n<li>Onlinef\u00e4higkeit<\/li>\n<li>nahtlosen Umschaltzeit von unter 1 Sekunde*<\/li>\n<li>256 Fremdsysteme\/UGS<\/li>\n<li>16 OPC-Server\/UGS<\/li>\n<li>600.000 Datenpunkte\/UGS<\/li>\n<li>450.000 Kommunikationsdatenpunkte\/UGS<\/li>\n<li>Durchsatzrate von 6.400 Daten\/sec.<\/li>\n<\/ul>\n<p style=\"padding-left: 30px\">*Einsatz von 2 <a href=\"https:\/\/web-material3.yokogawa.com\/GS33J20C20-01EN_001.pdf\">UGS<\/a><\/p>\n<p>Oder erfahren Sie mehr zu Yokogawas Systemstruktur <a href=\"http:\/\/www.yokogawa.com\/de\/dcs\/prozessleitsys\/de-systemstruktur.htm?nid=left\">hier<\/a>.<\/p>\n<p>Oder schreiben Sie Ihre Meinung zu dem Thema in die Kommentare. Ich freue mich \u00fcber den Austausch.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sich Neuen Technologien \u00f6ffnen, aber bei der Sicherheit keine Kompromisse machen. Dr. Krauss, BASF, sagt noch viel mehr in seinem Interview \u00fcber NAMUR Open Architecture auf der NAMUR-Hauptsitzung 2016. Trotzdem bringt die Aussage es auf den Punkt. Mit der NAMUR [&hellip;]<\/p>\n","protected":false},"author":105,"featured_media":956,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[957,961],"tags":[],"coauthors":[1000],"class_list":["post-3844","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-automation-de","category-security-de","author-thomas-schindler"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.7 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit - Chemical Pharma Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit\" \/>\n<meta property=\"og:description\" content=\"Sich Neuen Technologien \u00f6ffnen, aber bei der Sicherheit keine Kompromisse machen. Dr. Krauss, BASF, sagt noch viel mehr in seinem Interview \u00fcber NAMUR Open Architecture auf der NAMUR-Hauptsitzung 2016. Trotzdem bringt die Aussage es auf den Punkt. Mit der NAMUR [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemical Pharma Blog\" \/>\n<meta property=\"article:published_time\" content=\"2017-01-25T11:07:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-04T04:53:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"861\" \/>\n\t<meta property=\"og:image:height\" content=\"557\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Thomas Schindler\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\\\/\"},\"author\":{\"name\":\"Thomas Schindler\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#\\\/schema\\\/person\\\/adcd0fed5fe65f8f4d371d98235744b3\"},\"headline\":\"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit\",\"datePublished\":\"2017-01-25T11:07:37+00:00\",\"dateModified\":\"2022-07-04T04:53:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\\\/\"},\"wordCount\":281,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/Fotolia_100286097_S.jpg\",\"articleSection\":[\"Automation\",\"Security\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\\\/\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\\\/\",\"name\":\"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit - Chemical Pharma Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/Fotolia_100286097_S.jpg\",\"datePublished\":\"2017-01-25T11:07:37+00:00\",\"dateModified\":\"2022-07-04T04:53:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/Fotolia_100286097_S.jpg\",\"contentUrl\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/Fotolia_100286097_S.jpg\",\"width\":861,\"height\":557,\"caption\":\"Risk Management with Evaluation Process as Concept\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/\",\"name\":\"Chemical Pharma Blog\",\"description\":\"Just another blogs.yokogawa.com Sites site\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#organization\",\"name\":\"Chemical Pharma Blog\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/05\\\/yokogawa-logo-e1651674418793.png\",\"contentUrl\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/05\\\/yokogawa-logo-e1651674418793.png\",\"width\":302,\"height\":89,\"caption\":\"Chemical Pharma Blog\"},\"image\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#\\\/schema\\\/person\\\/adcd0fed5fe65f8f4d371d98235744b3\",\"name\":\"Thomas Schindler\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5beabf588cee7b992113f5c917a9bf0296fc9c16bb793eacd0f3f3c50c719b43?s=96&d=mm&r=g8cc8dfdf7bc718d4334ca6b54fe260e0\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5beabf588cee7b992113f5c917a9bf0296fc9c16bb793eacd0f3f3c50c719b43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5beabf588cee7b992113f5c917a9bf0296fc9c16bb793eacd0f3f3c50c719b43?s=96&d=mm&r=g\",\"caption\":\"Thomas Schindler\"},\"description\":\"responsible for Marketing Automation Solutions, expert for Distributed Control Systems, employed by Yokogawa since 1999\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/author\\\/thomas-schindler\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit - Chemical Pharma Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/","og_locale":"de_DE","og_type":"article","og_title":"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit","og_description":"Sich Neuen Technologien \u00f6ffnen, aber bei der Sicherheit keine Kompromisse machen. Dr. Krauss, BASF, sagt noch viel mehr in seinem Interview \u00fcber NAMUR Open Architecture auf der NAMUR-Hauptsitzung 2016. Trotzdem bringt die Aussage es auf den Punkt. Mit der NAMUR [&hellip;]","og_url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/","og_site_name":"Chemical Pharma Blog","article_published_time":"2017-01-25T11:07:37+00:00","article_modified_time":"2022-07-04T04:53:48+00:00","og_image":[{"width":861,"height":557,"url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg","type":"image\/jpeg"}],"author":"Thomas Schindler","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#article","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/"},"author":{"name":"Thomas Schindler","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/adcd0fed5fe65f8f4d371d98235744b3"},"headline":"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit","datePublished":"2017-01-25T11:07:37+00:00","dateModified":"2022-07-04T04:53:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/"},"wordCount":281,"commentCount":0,"publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg","articleSection":["Automation","Security"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/","name":"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit - Chemical Pharma Blog","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#primaryimage"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg","datePublished":"2017-01-25T11:07:37+00:00","dateModified":"2022-07-04T04:53:48+00:00","breadcrumb":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#primaryimage","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg","width":861,"height":557,"caption":"Risk Management with Evaluation Process as Concept"},{"@type":"BreadcrumbList","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/"},{"@type":"ListItem","position":2,"name":"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit"}]},{"@type":"WebSite","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/","name":"Chemical Pharma Blog","description":"Just another blogs.yokogawa.com Sites site","publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization","name":"Chemical Pharma Blog","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","width":302,"height":89,"caption":"Chemical Pharma Blog"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/adcd0fed5fe65f8f4d371d98235744b3","name":"Thomas Schindler","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/5beabf588cee7b992113f5c917a9bf0296fc9c16bb793eacd0f3f3c50c719b43?s=96&d=mm&r=g8cc8dfdf7bc718d4334ca6b54fe260e0","url":"https:\/\/secure.gravatar.com\/avatar\/5beabf588cee7b992113f5c917a9bf0296fc9c16bb793eacd0f3f3c50c719b43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5beabf588cee7b992113f5c917a9bf0296fc9c16bb793eacd0f3f3c50c719b43?s=96&d=mm&r=g","caption":"Thomas Schindler"},"description":"responsible for Marketing Automation Solutions, expert for Distributed Control Systems, employed by Yokogawa since 1999","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/author\/thomas-schindler\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg",861,557,false],"thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S-150x150.jpg",150,150,true],"medium":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S-300x194.jpg",300,194,true],"medium_large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S-768x497.jpg",768,497,true],"large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg",861,557,false],"1536x1536":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg",861,557,false],"2048x2048":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg",861,557,false],"post-thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S-356x200.jpg",356,200,true]},"uagb_author_info":{"display_name":"Thomas Schindler","author_link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/author\/thomas-schindler\/"},"uagb_comment_info":0,"uagb_excerpt":"Sich Neuen Technologien \u00f6ffnen, aber bei der Sicherheit keine Kompromisse machen. Dr. Krauss, BASF, sagt noch viel mehr in seinem Interview \u00fcber NAMUR Open Architecture auf der NAMUR-Hauptsitzung 2016. Trotzdem bringt die Aussage es auf den Punkt. Mit der NAMUR [&hellip;]","_links":{"self":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/3844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/users\/105"}],"replies":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/comments?post=3844"}],"version-history":[{"count":2,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/3844\/revisions"}],"predecessor-version":[{"id":11336,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/3844\/revisions\/11336"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/media\/956"}],"wp:attachment":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/media?parent=3844"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/categories?post=3844"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/tags?post=3844"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/coauthors?post=3844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}